PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-30

  1. 5,955 Posts.
    lightbulb Created with Sketch. 1138
    out of interest, who has been waiting for approval to buy more shares?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.